BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17637807)

  • 1. Risk estimation for familial breast cancer: improving the system of counselling.
    Gregory H; Wordsworth S; Gibbons B; Wilson B; Haites N
    Eur J Hum Genet; 2007 Nov; 15(11):1139-44. PubMed ID: 17637807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
    Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
    Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.
    Warner E; Heisey RE; Goel V; Carroll JC; McCready DR
    Can Fam Physician; 1999 Jan; 45():104-12. PubMed ID: 10889863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term attendance at follow-up of women assessed as being at increased risk of developing breast cancer in south-east Scotland.
    Holloway S; Porteous M; Cetnarskyj R; Anderson E; Campbell J; Steel M; Campbell H
    Community Genet; 2007; 10(4):252-60. PubMed ID: 17895631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.
    Hopwood P; Keeling F; Long A; Pool C; Evans G; Howell A
    Psychooncology; 1998; 7(5):402-12. PubMed ID: 9809331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health aspects of breast cancer gene testing in Canada. Part 3: A model of potential need and demand.
    Elwood JM
    Chronic Dis Can; 1999; 20(1):21-5. PubMed ID: 10352132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a risk assessment tool for women with a family history of breast cancer.
    Braithwaite D; Sutton S; Mackay J; Stein J; Emery J
    Cancer Detect Prev; 2005; 29(5):433-9. PubMed ID: 16055276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a surveillance programme for women with a family history of breast cancer.
    Reis MM; Tavakoli M; Dewar J; Goudie D; Cook A; McLeish L; Young D; Kenyon J; Steel M
    J Med Genet; 2009 May; 46(5):319-23. PubMed ID: 19279022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a family risk assessment clinic for breast cancer.
    Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
    Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
    Metcalfe A; Werrett J; Burgess L; Clifford C
    Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triaging referral to a specialist breast clinic.
    Hung WK; Chan SW; Suen DT; Chan MC; Lau Y; Yip AW
    ANZ J Surg; 2006 May; 76(5):310-2. PubMed ID: 16768688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members.
    Keller M; Jost R; Haunstetter CM; Sattel H; Schroeter C; Bertsch U; Cremer F; Kienle P; Tariverdian M; Kloor M; Gebert J; Brechtel A
    Clin Genet; 2008 Nov; 74(5):414-24. PubMed ID: 18954412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians.
    Chin TM; Tan SH; Lim SE; Iau P; Yong WP; Wong SW; Lee SC
    Cancer Detect Prev; 2005; 29(5):412-8. PubMed ID: 16185817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does dispositional optimism predict psychological responses to counseling for familial breast cancer?
    Norman P; Brain K
    J Psychosom Res; 2007 Sep; 63(3):247-54. PubMed ID: 17719361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The familial risk of breast cancer in women with endometriosis from Yale series.
    Matalliotakis IM; Cakmak H; Mahutte N; Goumenou AG; Koumantakis G; Arici A
    Surg Oncol; 2008 Dec; 17(4):289-93. PubMed ID: 18456491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Referral to cancer genetic counseling: are there stages of readiness?
    O'Neill SM; Peters JA; Vogel VG; Feingold E; Rubinstein WS
    Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):221-31. PubMed ID: 17068804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk perception among women receiving genetic counseling: a population-based follow-up study.
    Mikkelsen EM; Sunde L; Johansen C; Johnsen SP
    Cancer Detect Prev; 2007; 31(6):457-64. PubMed ID: 18061369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI screening in a clinic population with a family history of breast cancer.
    Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
    Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.